| Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics M Farre, R De La Torre, B Ó Mathúna, PN Roset, AM Peiro, M Torrens, ... Psychopharmacology 173, 364-375, 2004 | 185 | 2004 |
| Pharmacological interaction between 3, 4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics M Farré, S Abanades, PN Roset, AM Peiró, M Torrens, B O'Mathúna, ... Journal of Pharmacology and Experimental Therapeutics 323 (3), 954-962, 2007 | 146 | 2007 |
| Efficacy and tolerance of metamizole versus morphine for acute pancreatitis pain AM Peiró, J Martínez, E Martínez, E De Madaria, P Llorens, JF Horga, ... Pancreatology 8 (1), 25-29, 2008 | 89 | 2008 |
| Stereochemical analysis of 3, 4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3, 4-dihydroxymethamphetamine) N Pizarro, M Farré, M Pujadas, AM Peiró, PN Roset, J Joglar, ... Drug Metabolism and Disposition 32 (9), 1001-1007, 2004 | 83 | 2004 |
| Contribution of cytochrome P450 2D6 to 3, 4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe M Segura, M Farré, S Pichini, AM Peiró, PN Roset, A Ramírez, J Ortuno, ... Clinical pharmacokinetics 44, 649-660, 2005 | 81 | 2005 |
| Sleep problems in adults with autism spectrum disorder and intellectual disability P Ballester, MJ Martínez, A Javaloyes, MM Inda, N Fernández, P Gázquez, ... Autism Research 12 (1), 66-79, 2019 | 74 | 2019 |
| Human pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart AM Peiró, M Farré, PN Roset, M Carbó, M Pujadas, M Torrens, J Camí, ... Psychopharmacology 225, 883-893, 2013 | 53 | 2013 |
| Sleep in autism: a biomolecular approach to aetiology and treatment P Ballester, AL Richdale, EK Baker, AM Peiró Sleep Medicine Reviews 54, 101357, 2020 | 49 | 2020 |
| Electrochemically assisted deposition of titanium dioxide on aluminium cathodes AM Peiró, E Brillas, J Peral, X Domènech, JA Ayllón Journal of Materials Chemistry 12 (9), 2769-2773, 2002 | 45 | 2002 |
| Preparation of anatase powders from fluorine-complexed titanium (IV) aqueous solution using microwave irradiation JA Ayllon, AM Peiro, L Saadoun, E Vigil, X Domenech, J Peral Journal of Materials Chemistry 10 (8), 1911-1914, 2000 | 41 | 2000 |
| Gender based differences, pharmacogenetics and adverse events in chronic pain management B Planelles, C Margarit, MM Inda, P Ballester, J Muriel, J Barrachina, ... The pharmacogenomics journal 20 (2), 320-328, 2020 | 37 | 2020 |
| Club drugs: los viejos fármacos son las nuevas drogas de la fiesta S Abanades, AM Peiró, M Farré Medicina clínica 123 (8), 305-311, 2004 | 37 | 2004 |
| Benefits of emergency departments’ contribution to stroke prophylaxis in atrial fibrillation: the EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines … B Coll-Vinent, A Martín, J Sánchez, J Tamargo, C Suero, F Malagón, ... Stroke 48 (5), 1344-1352, 2017 | 33 | 2017 |
| Opioids increase sexual dysfunction in patients with non-cancer pain R Ajo, A Segura, MM Inda, B Planelles, L Martínez, G Ferrández, ... The journal of sexual medicine 13 (9), 1377-1386, 2016 | 32 | 2016 |
| Hepatotoxicity related to paraquat and diquat absorption through intact skin AM Peiró, P Zapater, C Alenda, A Ramírez, A Gutiérrez, M Pérez-Mateo, ... Digestive diseases and sciences 52, 3282-3284, 2007 | 31 | 2007 |
| Gender bias in therapeutic effort: from research to health care MT Ruiz-Cantero, M Blasco-Blasco, E Chilet-Rosell, AM Peiró Farmacia Hospitalaria 44 (3), 109-113, 2020 | 29* | 2020 |
| Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients J Muriel, C Margarit, J Barrachina, P Ballester, A Flor, D Morales, ... Basic & Clinical Pharmacology & Toxicology 124 (4), 439-448, 2019 | 29 | 2019 |
| Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability P Ballester, MJ Martínez, MM Inda, A Javaloyes, AL Richdale, J Muriel, ... Journal of Psychopharmacology 33 (11), 1395-1406, 2019 | 28 | 2019 |
| Multimorbidity and psychotropic polypharmacy among participants with autism spectrum disorder with intellectual disability C Espadas, P Ballester, AC Londoño, S Almenara, V Aguilar, C Belda, ... Psychiatry Research 292, 113321, 2020 | 27 | 2020 |
| OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients J Muriel, C Margarit, B Planelles, MJ Serralta, C Puga, MM Inda, E Cutillas, ... Annals of the New York Academy of Sciences 1425 (1), 82-93, 2018 | 26 | 2018 |
Mª Purificación Ballester NavarroPharmacology ProfessorDirección de correo verificada de ucam.edu
